Embecta Corp., (EMBC) Social Stream
EMBECTA CORP (EMBC) Price Targets From Analysts
Use the tables below to see what analysts covering EMBECTA CORP think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-15 | 2 | $25 | $25 | $25 | $17.41 | 43.6% |
| 2022-08-15 | 2 | $33 | $25 | $29 | $17.41 | 66.57% |
| 2022-08-16 | 2 | $36 | $25 | $30.5 | $17.41 | 75.19% |
| 2022-10-03 | 3 | $36 | $25 | $30.5 | $17.41 | 75.19% |
| 2022-12-21 | 3 | $31 | $25 | $28 | $17.41 | 60.83% |
| 2023-03-31 | 3 | $28 | $25 | $26.5 | $17.41 | 52.21% |
| 2023-05-15 | 3 | $25 | $25 | $25 | $17.41 | 43.6% |
| 2023-05-30 | 3 | $29 | $25 | $27 | $17.41 | 55.08% |
| 2023-06-06 | 3 | $29.001 | $25 | $27 | $17.41 | 55.08% |
| 2023-08-09 | 3 | $25 | $19 | $22 | $17.41 | 26.36% |
| 2023-08-23 | 3 | $25 | $16 | $20.5 | $17.41 | 17.75% |
| 2023-10-18 | 4 | $17 | $15 | $16 | $17.41 | -8.1% |
| 2023-12-04 | 4 | $17 | $16 | $16.5 | $17.41 | -5.23% |
| NA | 1 | $NA | $NA | $NA | $17.41 | NA% |
The Trend in the Analyst Price Target
Over the past 27 weeks, EMBC's average price target has gone down $10.5.
EMBC reports an average of -2.35% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-20 | 3 | 33 | 25 | 29.0 | 27.40 | 5.84% |
| 2023-01-06 | 3 | 28 | 25 | 26.5 | 25.05 | 5.79% |
| 2023-02-16 | 3 | 28 | 25 | 26.5 | 31.04 | -14.63% |
| 2023-03-31 | 3 | 28 | 25 | 26.5 | 28.12 | -5.76% |
| 2023-10-18 | 4 | 17 | 15 | 16.0 | 15.41 | 3.83% |
EMBC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3.58 | 0 | 0 | 2 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
EMBC's average broker recommendation rating improved by 0.25 over the prior 18 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, EMBECTA CORP's number of analysts covering the stock is higher than 103.13% of them.
- In the context of Healthcare stocks, EMBECTA CORP's variance in analysts' estimates is lower than -100.55% of them.
- In the context of Medical Equipment stocks, EMBECTA CORP's average analyst price target is higher than 481.35% of them.
- In terms of how EMBECTA CORP fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 490.03% of that group.
In the Medical Equipment industry, BIOL, RXST, and CHEK are the three stocks most similar to EMBECTA CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is EMBC a Buy, Hold or Sell? See the POWR Ratings now!